Havana, Mar 27 (Prensa Latina) Cuba’s Recombinant Human Interferon Alpha 2B is currently a hope for the world, which shows its concern about the lethality and spread of the coronavirus, SARS-Cov-2, which causes Covid-19 disease.
Amid the fight against this disease, declared a pandemic by the World Health Organization, more than 45 countries requested this drug produced in Cuba for its proven antiviral properties.
Since its introduction more than three decades ago in the national health system, this medicine has shown its efficacy and safety in the therapy of viral diseases such as Hepatitis B and C, Herpes zoster (popularly called shingles) and HIV/AIDS.
Its choice by the Chinese medical authorities to fight the novel coronavirus is due to the fact that these viruses generally decrease the natural production of interferon in the human body and the Cuban drug is capable of supplying such deficiency, strengthening the immune system of patients afflicted by the aforementioned respiratory ailment.
Interferon Alpha 2B received in 2012 the National Technological Innovation Prize, granted by the Ministry of Science, Technology and the Environment and the National Prize, Granma newspaper states.